Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn’s disease following ileocolonic resection
Crossref DOI link: https://doi.org/10.1007/s00384-016-2632-4
Published Online: 2016-07-31
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Yi
Stocchi, Luca
Rui, Yuanyi
Remzi, Feza H.
Shen, Bo
License valid from 2016-07-31